[1]任 格.白细胞预测急性心肌梗死患者院内死亡的临床价值[J].医学信息,2024,37(15):115-118.[doi:10.3969/j.issn.1006-1959.2024.15.026]
　REN Ge.Clinical Value of White Blood Cells in Predicting In-hospital Death in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2024,37(15):115-118.[doi:10.3969/j.issn.1006-1959.2024.15.026]
点击复制

白细胞预测急性心肌梗死患者院内死亡的临床价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年15期
页码:
115-118
栏目:
论著
出版日期:
2024-08-01

文章信息/Info

Title:
Clinical Value of White Blood Cells in Predicting In-hospital Death in Patients with Acute Myocardial Infarction
文章编号:
1006-1959（2024）15-0115-04
作者:
任 格
（北京航天总医院心内一科，北京 100076）
Author(s):
REN Ge
(The First Department of Cardiology,Beijing Aerospace General Hospital,Beijing 100076,China)
关键词:
急性心肌梗死; 白细胞; 预后
Keywords:
Acute myocardial infarction; White blood cells; Prognosis
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2024.15.026
文献标志码:
A
摘要:
目的 探讨白细胞预测急性心肌梗死（AMI）患者院内死亡的临床价值。方法 回顾性分析2014年1月-2022年10月我院接受治疗的AMI患者507例，根据白细胞数量分为A组[白细胞数量（4~10）×109/L]和B组（白细胞数量＞10×109/L），比较两组一般资料、院内病死率，并采用COX回归分析AMI患者死亡的预测因素。结果 两组白细胞数量、年龄、EF值、吸烟、术后他汀、服用血管活性药、MACE结果比较，差异有统计学意义（Ｐ＜0.05）；A组院内病死率为7.89‰，低于B组的92.70‰，差异有统计学意义（Ｐ＜0.05）。白细胞、中性粒细胞、年龄、心衰、血管活性药物是影响AMI患者死亡的独立因素，即白细胞高是白细胞正常发生死亡概率的0.993倍，中性粒细胞高是中性粒细胞正常的1.052倍，年龄大是年龄小的1.060倍，发生心衰是不发生心衰的4.423倍，不使用血管活性药是使用血管活性药物的0.282倍。结论 白细胞、中性粒细胞、年龄、心衰、血管活性药物是AMI死亡的预测因素，应用白细胞计数对患者结局的预测可以有助于临床决策。
Abstract:
Objective To investigate the clinical value of white blood cells in predicting in-hospital death in patients with acute myocardial infarction (AMI).Methods A total of 507 patients with AMI who were treated in our hospital from January 2014 to October 2022 were retrospectively analyzed. According to the number of white blood cells, they were divided into group A [white blood cell count (4-10)×109/L] and group B (white blood cell count>10×109/L). The general data and in-hospital mortality were compared between the two groups. COX regression was used to analyze the predictors of death in AMI patients.Results There were significant differences in the number of white blood cells, age, EF value, smoking, postoperative statins, taking vasoactive drugs and MACE results between the two groups (P<0.05). The in-hospital mortality of group A was 7.89‰, which was lower than 92.70‰ of group B, and the difference was statistically significant (P<0.05). White blood cells, neutrophils, age, heart failure, and vasoactive drugs are independent factors affecting the death of AMI patients, that was, the high white blood cell count was 0.993 times than of the death probability of normal white blood cell count, high neutrophils was 1.052 times than of the normal neutrophils, older was 1.060 times younger, and heart failure was 4.423 times than of the absence of heart failure, the non-use of vasoactive drugs was 0.282 times that of vasoactive drugs.Conclusion White blood cells, neutrophils, age, heart failure, and vasoactive drugs are predictors of AMI death. The application of white blood cell count to predict the outcome of patients can help clinical decision-making.

参考文献/References:

[1]马丽媛,吴亚哲,王文,等．《中国心血管病报告2017》要点解读[J].中国心血管杂志，2018，23(1):3-6．[2]中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2019概要[J].中国循环杂志,2020,35(9):833-854. [3]《中国心血管健康与疾病报告2020》编写组.《中国心血管健康与疾病报告2020》要点解读[J].中国心血管杂志,2021,26(3):209-218. [4]张京.高血压患者中性粒细胞/淋巴细胞比值在心脑血管事件中的预测价值[J].心血管病防治知识(学术版),2019,9(11):12-13.[5]Kristono GA,Holley AS,Harding SA,et al.White blood cell subtypes as predictors of adverse cardiac events[J].Coronary Artery Disease,2020,31(5):446-450.[6]Sasmita BR,Zhu Y,Gan H,et al.Leukocyte and its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study[J].Shock,2022,57(3):351-359.[7]Shah AD,Denaxas S,Nicholas O,et al.Neutrophil counts and initial presentation of 12 cardiovascular diseases: a CALIBER cohort study[J].Journal of the American College of Cardiology,2017,69(9):1160-1169.[8]舒美茹.2004-2018 年中国急性心肌梗死死亡率趋势及年龄-时期-队列模型的研究[D].沈阳:中国医科大学,2021.[9]刘永朱,黄莹,杜景柏.白细胞计数在急性冠状动脉综合征患者预后中的作用[J].检验医学与临床,2011,8(10):1216-1217.[10]黄舒洁,洪达,林圣美.全球急性冠状动脉事件注册评分联合血清可溶性白细胞介素6受体水平对急性心肌梗死患者术后主要不良心血管事件发生风险的预测价值[J].中国医药,2023,18(2):178-182.[11]伍小山,罗华.中性粒细胞与淋巴细胞比值对急性大面积脑梗死患者出血性转化的预测价值研究[J].实用心脑肺血管病杂志,2020,28(1):37-42.[12]李振勇,路雯,冯春光,等.急性心肌梗死病人急诊经皮冠状动脉介入治疗术后冠脉慢血流-无血流现象的预测因素[J].实用老年医学,2018,32(12):1173-1176.[13]徐阳,韩拓,刘莉君,等.血小板/白蛋白和血小板/血红蛋白及C-反应蛋白/白蛋白各比值与糖尿病患病的相关性分析[J].西安交通大学学报(医学版),2022,43(3):348-353.[14]孟帅,张鼎,许戈,等.非高密度脂蛋白胆固醇对急性心肌梗死患者经皮冠状动脉介入治疗后远期预后的影响研究[J].实用心脑肺血管病杂志,2021,29(6):34-39. [15]史苏娜,侯维娜,李振莲,等.急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗术后炎性因子的变化对院内主要不良心血管事件的预测价值[J].心脏杂志,2022,34(4):422-427.[16]王艳飞,王华荣,赵春生,等.休克指数及中性粒细胞/淋巴细胞比值对急性非ST段抬高心肌梗死患者短期预后的预测价值[J].中国急救医学,2019,39(12):1159-1163. [17]黄丽,齐洁,崔建国,等.中性粒细胞/淋巴细胞比值与慢性心力衰竭急性发作患者院内死亡的相关性研究[J].临床心血管病杂志,2020,36(2):138-142.[18]赵文奇,蒋海霞.急性心肌梗死行急诊经皮冠状动脉介入和择期经皮冠状动脉介入治疗的近期疗效及远期安全性对比分析[J].中国药物与临床,2018,18(11):1957-1958. [19]江晓波.老年急性ST段抬高型心肌梗死患者不同时机行经皮冠状动脉介入支架植入疗效及心血管不良事件对比[J].中外医学研究,2018,16(29):1-3. [20]陈焱,陈胜岳,韩元元,等.中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值对急性心肌梗死患者住院死亡风险的联合预测价值[J].中国全科医学,2023,26(20):2482-2487. [21]王海斌,高晓丽,谢明,等.中性粒细胞与淋巴细胞的比值对老年急性ST段抬高型心肌梗死冠状动脉介入术远期预后的预测价值[J].中国实用内科杂志,2022,42(2):146-150.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
　GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(15):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
　YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Journal of Medical Information,2018,31(15):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者 心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
　MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(15):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[4]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并 心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
　LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Journal of Medical Information,2018,31(15):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[5]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
　GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(15):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[6]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
　HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(15):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[7]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
　CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(15):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
[8]韦能宝,薛志刚,毕金文.尿源性脓毒血症诊治分析[J].医学信息,2018,31(24):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
　WEI Neng-bao,XUE Zhi-gang,BI Jin-wen.Diagnosis and Treatment of Urinary Sepsis[J].Journal of Medical Information,2018,31(15):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
[9]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
　GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2019,32(15):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[10]杨 震.急性心梗直接介入治疗术中慢血流及无复流的治疗进展[J].医学信息,2019,32(06):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]
　YANG Zhen.Progress in the Treatment of Slow Blood Flow and no Reflow in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2019,32(15):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]

更新日期/Last Update: 1900-01-01